Approval · Notice of Compliance 13174 · 2012
FORANE: Notice of Compliance 13174
Issued March 30, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13174
- Date
- March 30, 2012
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised indication: Forane (Isoflurane) is indicated for induction and maintenance of gerneal anesthesia. Revisions to the Product Monograph
- Therapeutic class
- Inhalation Anesthetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FORANE | Not yet assigned | — |
Medicinal ingredients
- ISOFLURANE 100 PER